Clearbridge Investments LLC Has $18.66 Million Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Clearbridge Investments LLC lowered its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 238,981 shares of the company’s stock after selling 201 shares during the period. Clearbridge Investments LLC owned approximately 0.48% of Prestige Consumer Healthcare worth $18,662,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Cerity Partners LLC raised its position in shares of Prestige Consumer Healthcare by 103.9% in the 3rd quarter. Cerity Partners LLC now owns 6,347 shares of the company’s stock valued at $458,000 after buying an additional 3,234 shares in the last quarter. BNP Paribas Financial Markets increased its stake in Prestige Consumer Healthcare by 276.2% in the third quarter. BNP Paribas Financial Markets now owns 17,379 shares of the company’s stock valued at $1,253,000 after acquiring an additional 12,759 shares during the last quarter. Paloma Partners Management Co bought a new position in Prestige Consumer Healthcare in the third quarter valued at approximately $274,000. HighTower Advisors LLC raised its position in Prestige Consumer Healthcare by 4.9% during the third quarter. HighTower Advisors LLC now owns 16,708 shares of the company’s stock valued at $1,215,000 after purchasing an additional 774 shares in the last quarter. Finally, Stifel Financial Corp lifted its stake in Prestige Consumer Healthcare by 13.7% during the third quarter. Stifel Financial Corp now owns 19,299 shares of the company’s stock worth $1,391,000 after purchasing an additional 2,322 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Wall Street Analyst Weigh In

PBH has been the topic of several recent analyst reports. DA Davidson lifted their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Tuesday, March 18th. Canaccord Genuity Group increased their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Sidoti downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target on the stock. in a research note on Monday, December 9th. Finally, Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $93.33.

Prestige Consumer Healthcare Price Performance

PBH stock opened at $86.23 on Thursday. The company has a market capitalization of $4.27 billion, a P/E ratio of 20.19, a PEG ratio of 2.69 and a beta of 0.46. The company has a fifty day moving average price of $83.76 and a 200-day moving average price of $79.30. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Insider Activity at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the transaction, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is currently owned by company insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.